At 15.5x earnings and 1.4x book, Berkshire is not expensive for a $1,034,959M financial conglomerate, but the 22.1 forward P/E and 2.5 forward PEG suggest growth is decelerating relative to price. The absence of an Altman Z-Score removes a key balance sheet safety signal, but a modest 7.80% ROE and 8.50% ROIC indicate steady, not exceptional, capital efficiency. Operating margins of 9.30% in a diversified insurance structure show resilience but not dominance. This is not a distressed value play; it is a fairly valued, slow-compounding capital allocator priced for durability rather than acceleration. The market is not dramatically mispricing it—this looks like a stability premium rather than a growth bargain.